| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $-0.58 (Miss by $-0.39) |
| EPS GAAP Actual | $-0.58 (Miss by $-0.39) |
| Revenue Actual | $0.8901B |
| Revenue Surprise | Beat by $890.1M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.54197 |
| EPS GAAP Estimate | $0.54197 |
| Revenue Estimate | $1.0255634B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0 | INF | 0 | 0 | 1 |
| Dec 2027 | 2.84 | 10.54 | 2.69211 | 2.94037 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.23 | -0.8662 | 0.8901B | -17.07% | -17.28M |
| FQ1 2025 (Mar 2025) | 0.28 | 0.28 | 0.937B | -4.97% | 937M |
| FQ4 2024 (Dec 2024) | 0.27 | 0.27 | 1.1231B | -9.96% | 1123.1M |
| FQ3 2024 (Sep 2024) | 0.72 | 0.72 | 1.088B | 0.84% | 1088M |
| FQ2 2024 (Jun 2024) | 0 | 0 | 1.042B | -21.77% | 1042M |
| FQ1 2024 (Mar 2024) | 0.31 | 0.31 | 0.9836B | -38.67% | 983.6M |
| FQ4 2023 (Dec 2023) | 1.3 | 1.3 | 1.235B | 100% | 1235M |
| FQ3 2023 (Sep 2023) | 0.9 | 0.9 | 1.0789B | 100% | 1078.9M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.54197
Consensus Revenue Estimates
1.0255634B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.64839 | -- | 0.63601 | 0.66148 | 1 |
| FQ3 2027 (Sep 2027) | 0.96 | -- | 0.95868 | 0.96132 | 1 |
| FQ2 2027 (Jun 2027) | 0.96 | -- | 0.95868 | 0.96132 | 1 |
| FQ1 2027 (Mar 2027) | 0.6987 | -- | 0.68536 | 0.71281 | 1 |
| FQ4 2026 (Oct 2026) | 0.89 | -- | 0.88511 | 0.89645 | 0 |
| FQ3 2026 (Jul 2026) | 0.88 | -- | 0.87516 | 0.88638 | 0 |
| FQ2 2026 (Jun 2026) | 1.04 | 122.12 | 1.01996 | 1.05732 | 0 |
| FQ1 2026 (Mar 2026) | 1.06 | 73.58 | 1.03958 | 1.07765 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.99B | -- | 0.98B | 1.01B | 1 |
| FQ3 2027 (Sep 2027) | 1.26B | -- | 1.26B | 1.26B | 1 |
| FQ2 2027 (Jun 2027) | 1.22B | -- | 1.22B | 1.22B | 1 |
| FQ1 2027 (Mar 2027) | 0.99B | -- | 0.97B | 1B | 1 |
| FQ4 2026 (Oct 2026) | 1.07B | -- | 1.06B | 1.07B | 0 |
| FQ3 2026 (Jul 2026) | 1.05B | -- | 1.05B | 1.06B | 0 |
| FQ2 2026 (Jun 2026) | 4.32B | 79.41 | 4.26B | 4.38B | 0 |
| FQ1 2026 (Mar 2026) | 4.01B | 76.66 | 3.95B | 4.07B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.6362 | -0.23 | -0.8662 | 376.61% |
| FQ1 2025 (Mar 2025) | 0.28 | 0.28 | 100% | |
| FQ4 2024 (Dec 2024) | 0.27 | 0.27 | 100% | |
| FQ3 2024 (Sep 2024) | 0.72 | 0.72 | 100% | |
| FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | 0.31 | 0.31 | 100% | |
| FQ4 2023 (Dec 2023) | 1.3 | 1.3 | 100% | |
| FQ3 2023 (Sep 2023) | 0.9 | 0.9 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0.91B | $0.89B | $-17.28M | -1.94% |
| FQ1 2025 (Mar 2025) | $0B | $0.94B | $937M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.12B | $1123.1M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.09B | $1088M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.04B | $1042M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.98B | $983.6M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.24B | $1235M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $1.08B | $1078.9M | 100% |